Covalon Technologies Ltd.
CVALF
Price:
$2.65
Market Cap:
$101.50M
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, Europe, the Middle East, Asia, Latin America, and internationally. The company has 3 proprietary platform technologies, including collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; antimicrobial silicone adhesive platform that is used for family of pre and post-surgical, and vascular access ...[Read more]
Industry
Biotechnology
IPO Date
2007-04-18
Stock Exchange
PNK
Ticker
CVALF
PE Ratio
[-88.33]
ROE
[-4.23%]
Current Ratio
[5.24]
Dividend Yield
[0%]
Enterprise Value
[93.17M]
Dividend History
The ROE as of November 2024 (TTM) for Covalon Technologies Ltd. (CVALF) is -4.23%
According to Covalon Technologies Ltd.’s latest financial reports and current stock price. The company's current ROE is -4.23%. This represents a change of 177.87% compared to the average of -1.52% of the last 4 quarters.
Covalon Technologies Ltd. (CVALF) Historical ROE (quarterly & annually)
How has CVALF ROE performed in the past?
The mean historical ROE of Covalon Technologies Ltd. over the last ten years is -17.12%. The current -4.23% ROE has changed -75.32% with respect to the historical average. Over the past ten years (40 quarters), CVALF's ROE was at its highest in in the September 2021 quarter at 67.03%. The ROE was at its lowest in in the September 2016 quarter at -56.17%.
Average
-17.12%
Median
-21.71%
Minimum
-85.79%
Maximum
70.34%
Covalon Technologies Ltd. (CVALF) ROE by Quarter and Year
Discovering the peaks and valleys of Covalon Technologies Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 312.96%
Maximum Annual ROE = 70.34%
Minimum Annual Increase = -644.89%
Minimum Annual ROE = -85.79%
| Year | ROE | Change |
|---|---|---|
| 2023 | -23.74% | -40.48% |
| 2022 | -39.88% | -156.70% |
| 2021 | 70.34% | -182.00% |
| 2020 | -85.79% | 27.74% |
| 2019 | -67.16% | -644.89% |
| 2018 | 12.33% | -38.90% |
| 2017 | 20.17% | -124.82% |
| 2016 | -81.28% | 312.96% |
| 2015 | -19.68% | -145.30% |
| 2014 | 43.45% | -228.90% |
Covalon Technologies Ltd. (CVALF) Average ROE
How has CVALF ROE performed in the past?
The current ROE of Covalon Technologies Ltd. (CVALF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.24%
5-year avg
-29.24%
10-year avg
-17.12%
Covalon Technologies Ltd. (CVALF) ROE vs. Peers
How is CVALF’s ROE compared to its peers?
Covalon Technologies Ltd.’s ROE is greater than Biotron Limited (-504.53%), less than Bioasis Technologies Inc. (0%), less than Mosaic ImmunoEngineering Inc. (5.79%), greater than Ceapro Inc. (-21.67%), greater than Cellectis S.A. (-76.69%), less than Resverlogix Corp. (12.20%), greater than Small Pharma Inc. (-78.43%), less than Advanced Proteome Therapeutics Corporation (0%), less than ChitogenX Inc. (0%), less than null (27.19%),
| Company | ROE | Market cap |
|---|---|---|
| -504.53% | $11.30M | |
| 0% | $284.08K | |
| 5.79% | $7.24M | |
| -21.67% | $13.31M | |
| -76.69% | $183.12M | |
| 12.20% | $11.23M | |
| -78.43% | $37.51M | |
| 0% | $147.12K | |
| 0% | $423.96K | |
| 27.19% | $0 |
Build a custom stock screener for Covalon Technologies Ltd. (CVALF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Covalon Technologies Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Covalon Technologies Ltd. (CVALF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Covalon Technologies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Covalon Technologies Ltd.'s ROE?
How is the ROE calculated for Covalon Technologies Ltd. (CVALF)?
What is the highest ROE for Covalon Technologies Ltd. (CVALF)?
What is the 3-year average ROE for Covalon Technologies Ltd. (CVALF)?
What is the 5-year average ROE for Covalon Technologies Ltd. (CVALF)?
How does the current ROE for Covalon Technologies Ltd. (CVALF) compare to its historical average?